2027 Request for Proposals - ADDF-Harrington Scholar Program
The ADDF-Harrington Scholar Program funds academic research developing innovative therapeutics for Alzheimer’s and dementias, supporting translational projects with expert drug development guidance.
Funder: Alzheimer's Drug Discovery Foundation
Due Dates: June 1, 2026 (Letter of Intent) | August 17, 2026 (Full proposal, invited)
Funding Amounts: Up to $600,000 over 2 years; milestone-driven; up to two awards annually
Summary: Supports academic drug discovery projects advancing novel therapeutics for Alzheimer’s disease and related dementias, with funding and expert development support.
Key Information: Open to academic investigators in the US, Canada, and UK; excludes anti-amyloid approaches.
Description
The ADDF-Harrington Scholar Program is a collaborative initiative between the Alzheimer's Drug Discovery Foundation (ADDF) and the Harrington Discovery Institute. Its mission is to accelerate the translation of academic discoveries into medicines for Alzheimer’s disease and related dementias. The program targets projects that are ready to move from hit-to-lead optimization through IND-enabling studies, supporting all drug modalities (e.g., small molecules, antibodies, peptides, oligonucleotides, gene therapies).
Awardees receive not only significant funding but also access to a tailored team of pharmaceutical industry experts in drug development, regulatory strategy, and commercialization. The program emphasizes innovative, translational science with strong potential for clinical and commercial impact.
